Literature DB >> 22986109

Clinical evidence of sustained chronic inflammatory reaction in retinitis pigmentosa.

Noriko Yoshida1, Yasuhiro Ikeda, Shoji Notomi, Keijiro Ishikawa, Yusuke Murakami, Toshio Hisatomi, Hiroshi Enaida, Tatsuro Ishibashi.   

Abstract

PURPOSE: To study the nature of inflammatory reaction in eyes of patients with retinitis pigmentosa (RP) and its possible role in the pathogenesis of RP.
DESIGN: Retrospective, observational study. PARTICIPANTS AND CONTROLS: Three hundred seventy-one consecutive patients diagnosed with typical RP were included in this study. We included 165 patients without active inflammatory diseases, including 20 patients diagnosed with cataract, and 36 patients diagnosed with idiopathic epiretinal membrane as controls.
METHODS: Density of the inflammatory cells in the anterior vitreous cavity was measured and graded by slit-lamp biomicroscopy. A multiplex enzyme-linked immunosorbent assay (ELISA) was performed to evaluate the concentration of cytokines and chemokines in aqueous humor and vitreous fluid of patients with RP and controls. In addition, we investigated the relationship between visual function and anterior vitreous cells in these patients. MAIN OUTCOME MEASURES: Slit-lamp biomicroscopic analysis, best-corrected visual acuity, visual field analysis, and multiplex ELISA.
RESULTS: In 190 of 509 eyes with RP (37.3%), "1+" (5-9 cells per field) or more cells were observed in the anterior vitreous cavity. Strong inflammatory reaction with "2+" cells (10-30 cells per field) was associated with younger age. In the elderly patients with RP, significantly decreased visual function was seen in a group with "1+" or more cells (P<0.05). Moreover, the levels of a variety of proinflammatory cytokines and chemokines, including monocyte chemotactic protein-1, were increased both in the aqueous humor and vitreous fluid of RP patients compared with the levels in control patients.
CONCLUSIONS: Sustained chronic inflammatory reaction may underlie the pathogenesis of RP, suggesting interventions for ocular inflammatory reaction as a potential treatment for patients with RP. FINANCIAL DISCLOSURE(S): The authors have no proprietary or commercial interest in any of the materials discussed in this article.
Copyright © 2013 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22986109     DOI: 10.1016/j.ophtha.2012.07.006

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  79 in total

1.  Changes in morphology and visual function over time in mouse models of retinal degeneration: an SD-OCT, histology, and electroretinography study.

Authors:  Tomoko Hasegawa; Hanako O Ikeda; Noriko Nakano; Yuki Muraoka; Tatsuaki Tsuruyama; Keiko Okamoto-Furuta; Haruyasu Kohda; Nagahisa Yoshimura
Journal:  Jpn J Ophthalmol       Date:  2016-01-05       Impact factor: 2.447

2.  NGF/anti-VEGF combined exposure protects RCS retinal cells and photoreceptors that underwent a local worsening of inflammation.

Authors:  Maria Luisa Rocco; Bijorn Omar Balzamino; Graziana Esposito; Carla Petrella; Luigi Aloe; Alessandra Micera
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-12-24       Impact factor: 3.117

3.  Intravitreal dexamethasone implant for recalcitrant cystoid macular edema secondary to retinitis pigmentosa: a pilot study.

Authors:  Aditya Sudhalkar; Laurent Kodjikian; Nishikant Borse
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-04-04       Impact factor: 3.117

Review 4.  The emerging role of interleukin (IL)-1 in the pathogenesis and treatment of inflammatory and degenerative eye diseases.

Authors:  Claudia Fabiani; Jurgen Sota; Gian Marco Tosi; Rossella Franceschini; Bruno Frediani; Mauro Galeazzi; Donato Rigante; Luca Cantarini
Journal:  Clin Rheumatol       Date:  2016-12-28       Impact factor: 2.980

5.  TNFa knockdown in the retina promotes cone survival in a mouse model of autosomal dominant retinitis pigmentosa.

Authors:  Tapasi Rana; Pravallika Kotla; Roderick Fullard; Marina Gorbatyuk
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2016-11-14       Impact factor: 5.187

6.  MUTYH promotes oxidative microglial activation and inherited retinal degeneration.

Authors:  Shunji Nakatake; Yusuke Murakami; Yasuhiro Ikeda; Noriko Morioka; Takashi Tachibana; Kohta Fujiwara; Noriko Yoshida; Shoji Notomi; Toshio Hisatomi; Shigeo Yoshida; Tatsuro Ishibashi; Yusaku Nakabeppu; Koh-Hei Sonoda
Journal:  JCI Insight       Date:  2016-09-22

7.  Vitritis in pediatric genetic retinal disorders.

Authors:  Maria Stunkel; Sajag Bhattarai; Andrew Kemerley; Edwin M Stone; Kai Wang; Robert F Mullins; Arlene V Drack
Journal:  Ophthalmology       Date:  2014-09-10       Impact factor: 12.079

Review 8.  Anthocyanin can arrest the cone photoreceptor degeneration and act as a novel treatment for retinitis pigmentosa.

Authors:  Ye Tao; Tao Chen; Guo-Qing Yang; Guang-Hua Peng; Zhong-Jun Yan; Yi-Fei Huang
Journal:  Int J Ophthalmol       Date:  2016-01-18       Impact factor: 1.779

9.  Management of Retinitis Pigmentosa via Platelet-Rich Plasma or Combination with Electromagnetic Stimulation: Retrospective Analysis of 1-Year Results.

Authors:  Umut Arslan; Emin Özmert
Journal:  Adv Ther       Date:  2020-04-18       Impact factor: 3.845

10.  Focal choroidal excavation with macular hole in a case of advanced retinitis pigmentosa.

Authors:  Raj Shri Hirawat; C K Nagesha; Chanchal Poddar
Journal:  Indian J Ophthalmol       Date:  2020-10       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.